[go: up one dir, main page]

PE20050502A1 - Tabletas que contienen enrofloxacina y saborizante de carne - Google Patents

Tabletas que contienen enrofloxacina y saborizante de carne

Info

Publication number
PE20050502A1
PE20050502A1 PE2004000619A PE2004000619A PE20050502A1 PE 20050502 A1 PE20050502 A1 PE 20050502A1 PE 2004000619 A PE2004000619 A PE 2004000619A PE 2004000619 A PE2004000619 A PE 2004000619A PE 20050502 A1 PE20050502 A1 PE 20050502A1
Authority
PE
Peru
Prior art keywords
weight
enrofloxacin
meat
tablets
adjuvants
Prior art date
Application number
PE2004000619A
Other languages
English (en)
Inventor
Venkata-Rangarao Kanikanti
Sabine Becker
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33520986&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20050502(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of PE20050502A1 publication Critical patent/PE20050502A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

QUE COMPRENDEN: I))20% A 45%, EN PESO, DE ENROFLOXACINO; II)18% A 35%, EN PESO, DE LACTOSA; III)5% A 10%, EN PESO, DE CELULOSA MICROCRISTALINA; Y, IV)5% A 20%, EN PESO, DE AROMA DE CARNE. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION DE DICHOS COMPRIMIDOS, QUE COMPRENDE: 1)MEZCLAR ENROFLOXACINO, LACTOSA, DE SER EL CASO AROMA DE CARNE Y OTROS COADYUVANTES; 2)GRANULAR LA MEZCLA CON ADICION DE AGUA O SOLUCIONES ACUOSAS DE OTROS COADYUVANTES; 3)SECAR LA MEZCLA; 4)ANADIR CELULOSA MICROCRISTALINA, LUEGO DEL SECADO Y DE SER EL CASO OTROS COADYUVANTES, ASI COMO AROMA DE CARNE, SI NO SE ANADIO, EN EL PASO (I); 5)COMPRIMIR LA MEZCLA A FIN DE FORMAR LOS COMPRIMIDOS. LOS COMPRIMIDOS DESCRITOS SON PARA SER ADMINISTRADOS A ANIMALES
PE2004000619A 2003-06-26 2004-06-25 Tabletas que contienen enrofloxacina y saborizante de carne PE20050502A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10328666A DE10328666A1 (de) 2003-06-26 2003-06-26 Tabletten enthaltend Geschmacks-und/oder Aromastoffe

Publications (1)

Publication Number Publication Date
PE20050502A1 true PE20050502A1 (es) 2005-08-18

Family

ID=33520986

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000619A PE20050502A1 (es) 2003-06-26 2004-06-25 Tabletas que contienen enrofloxacina y saborizante de carne

Country Status (30)

Country Link
US (1) US20090028936A1 (es)
EP (1) EP1641439B1 (es)
JP (2) JP5427341B2 (es)
KR (1) KR101119917B1 (es)
CN (1) CN100548280C (es)
AR (2) AR044704A1 (es)
AU (1) AU2004251003B2 (es)
BR (1) BRPI0411771B1 (es)
CA (1) CA2530639C (es)
CO (1) CO5650223A2 (es)
CR (1) CR8149A (es)
DE (2) DE10328666A1 (es)
DK (1) DK1641439T3 (es)
ES (1) ES2280973T3 (es)
GT (1) GT200400124A (es)
IL (1) IL172739A (es)
MX (1) MXPA05013875A (es)
MY (1) MY135825A (es)
NO (1) NO338438B1 (es)
NZ (1) NZ544365A (es)
PE (1) PE20050502A1 (es)
PL (1) PL1641439T3 (es)
PT (1) PT1641439E (es)
RU (1) RU2359699C2 (es)
SI (1) SI1641439T1 (es)
TW (1) TWI339124B (es)
UA (1) UA82529C2 (es)
UY (1) UY28380A1 (es)
WO (1) WO2005000275A1 (es)
ZA (1) ZA200510318B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100341510C (zh) * 2005-06-10 2007-10-10 冯莉萍 一种恩诺沙星微囊及制备方法
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
EP2343089A4 (en) * 2008-09-23 2013-05-01 Jaer S A Lab USE OF XYLITOL OR DERIVATIVES THEREOF FOR MASKING THE TASTE OF CHEMOTHERAPEUTIC MEDICAMENTS OF THE CHINOLO-N-NAPHTHYRIDONE-CARBOXYLIC ACID GROUP FOR PIG DICULTINATION
RU2412704C1 (ru) * 2009-07-08 2011-02-27 Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Великолукская государственная сельскохозяйственная академия" Способ лечения рожи свиней
MX347401B (es) * 2012-11-14 2017-04-18 Univ Mexico Nac Autonoma Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos.
UA118748C2 (uk) 2012-12-19 2019-03-11 Байєр Енімал Хелс Гмбх Таблетки, що мають покращене сприйняття та хорошу стабільність при зберіганні
RU2554748C2 (ru) * 2013-07-09 2015-06-27 Общество с ограниченной ответственностью "БИОН" Средство для лечения энтеритов у животных
MX356443B (es) * 2013-12-11 2018-05-21 Univ Mexico Nac Autonoma Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
AU2345192A (en) * 1992-07-21 1994-02-14 Boots Company Plc, The Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
BRPI9802144B1 (pt) * 1997-05-30 2017-03-28 Ezequiel Mayorga Jorge dispositivo osmótico multicapa aperfeiçoado
US5980914A (en) * 1997-08-22 1999-11-09 P.N. Gerolymatos S.A. Clioquinol for the treatment of Parkinson's disease
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
EP1247456A3 (en) * 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals

Also Published As

Publication number Publication date
ZA200510318B (en) 2007-04-25
KR101119917B1 (ko) 2012-02-29
CR8149A (es) 2007-09-12
UA82529C2 (uk) 2008-04-25
DE502004002690D1 (de) 2007-03-08
CN1812769A (zh) 2006-08-02
JP2007506658A (ja) 2007-03-22
MXPA05013875A (es) 2006-07-06
RU2006102033A (ru) 2006-06-10
IL172739A0 (en) 2006-04-10
AR103567A2 (es) 2017-05-17
IL172739A (en) 2010-12-30
AU2004251003A1 (en) 2005-01-06
MY135825A (en) 2008-07-31
BRPI0411771B1 (pt) 2015-11-24
UY28380A1 (es) 2005-01-31
HK1095515A1 (zh) 2007-05-11
AR044704A1 (es) 2005-09-21
NO338438B1 (no) 2016-08-15
GT200400124A (es) 2005-03-03
PL1641439T3 (pl) 2007-08-31
RU2359699C2 (ru) 2009-06-27
AU2004251003B2 (en) 2010-09-16
CN100548280C (zh) 2009-10-14
SI1641439T1 (sl) 2007-06-30
TWI339124B (en) 2011-03-21
DE10328666A1 (de) 2005-01-13
JP2012046533A (ja) 2012-03-08
BRPI0411771A (pt) 2006-08-29
EP1641439A1 (de) 2006-04-05
EP1641439B1 (de) 2007-01-17
ES2280973T3 (es) 2007-09-16
WO2005000275A1 (de) 2005-01-06
CA2530639A1 (en) 2005-01-06
NO20060065L (no) 2006-01-05
CA2530639C (en) 2012-01-03
KR20060063802A (ko) 2006-06-12
JP5427341B2 (ja) 2014-02-26
CO5650223A2 (es) 2006-06-30
NZ544365A (en) 2009-10-30
PT1641439E (pt) 2007-04-30
DK1641439T3 (da) 2007-04-10
US20090028936A1 (en) 2009-01-29
TW200503759A (en) 2005-02-01

Similar Documents

Publication Publication Date Title
PE53998A1 (es) Procedimiento para la produccion de un producto alimenticio granular
RU2013120907A (ru) Мягкие жвачки, не содержащие крахмала
PE20050502A1 (es) Tabletas que contienen enrofloxacina y saborizante de carne
AR065096A1 (es) Preparacion solida
BR0315297A (pt) Mistura de agregado seca, método de moldagem em fundição usando-se a mistura de agregado seca e núcleo de fundição
AR018607A1 (es) Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion
BR0214706A (pt) Estrutura absorvente envolta
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
RU2009147264A (ru) Непроницаемые капсулы
CN207378583U (zh) 一种用于矿物盐灯的盐汽呼吸通道
UA101407C2 (ru) Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат
AR019899A1 (es) Composicion farmaceutica y un procedimiento para prepararla.
ES2301455T1 (es) Composicion farmaceutica antiacida en forma de polvo; preparacion farmaceutica que contiene la misma y procedimiento para su preparacion.
EA201100288A1 (ru) Таблетки телмисартана
EA200602187A1 (ru) Фармацевтическая композиция и способ её получения
IL182549A (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
RU2513875C1 (ru) Шихта для производства пористого заполнителя
KR950010775A (ko) 칼슘 및 비타민이 함유된 과립형 설탕의 제조방법 및 조성물
Manninen et al. Rat metabolic adaptation to ammonia inhalation
CR7672A (es) Metodo microbiologico para la produccion de 11- alfa- hidroxiesteroides 7- alfa sustituidos
RU2514479C1 (ru) Сырьевая смесь для производства керамзита
RU2000116063A (ru) Биологически активная добавка "желудочные"
RU2003116703A (ru) Комплексная добавка для сухих строительных смесей
EA201170326A1 (ru) Дисперсия для применения в бетонной смеси
RU2013130802A (ru) Диспергируемая таблетка смектита диоктаэдрического и способ ее получения

Legal Events

Date Code Title Description
FG Grant, registration